(Q42480676)

1 November 2017

title

Guidelines for the management of basal cell carcinoma. British Association of Dermatologists (English)

1 reference

1 November 2017

Telfer NR

1

1 reference

1 November 2017

Colver GB

series ordinal

2

1 reference

1 November 2017

Bowers PW

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

British Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

141

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

415-423

1 reference

Treatment of skin cancer using multiple modalities

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Prediction of Subclinical Tumor Infiltration in Basal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Trends in the presentation and treatment of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Risk of developing another basal cell carcinoma. A 5-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Recurrence Rates of Treated Basal Cell Carcinomas: Part 2: Curettage-Electrodesiccation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Failure of curettage and electrodesiccation for removal of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epitheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Electrocoagulation for skin cancer: An old oncologic tool revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The treatment of basal cell carcinoma by curettage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Statistical data on malignant tumors in cryosurgery: 1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Cryosurgery of cutaneous carcinomas. An 18-year study of 3,022 patients with 4,228 carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Cryosurgery for malignancies of the eyelid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Cryosurgery of eyelid basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Treatment of basal-cell carcinomas by a combination of curettage and cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Basal cell carcinoma--a review of treatment results with special reference to cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Laser microsurgery for superficial T1-T2 basal cell carcinoma of the eyelid margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Multivariate risk score for recurrence of cutaneous basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Scalpel Excision of Basal Cell Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Curative and aesthetic results of surgical treatment of 138 basal-cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Use of frozen section analysis in the treatment of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Combined curettage and excision: a treatment method for primary basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Surgical margins for basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Significance of Marginal Extension in Excised Basal-Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Observations on the inadequately excised basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The significance of incomplete excision in patients with basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

A management approach to incompletely excised basal cell carcinomas of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Chemosurgery: My 15 Years of Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Mohs' technique (cancer chemosurgery). Treatment of recurrent cutaneous carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Microscopie-controlled excision of cutaneous tumors: chemosurgery, fresh tissue technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Recurrence Rates of Treated Basal Cell Carcinomas: Part 4: X-Ray Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Topical chemotherapy with 5-fluorouracil. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Indurated telangiectatic plaques. Malignant angioendotheliomatosis (MAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The Biologic Behavior of Basal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

The value of typing basal cell carcinomas in predicting recurrence after surgical excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Recurrence rates of treated basal cell carcinomas. Part 1: Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Aggressive Biologic Behavior of Basal- and Squamous-Cell Cancers in Patients with Chronic Lymphocytic Leukemia or Chronic Lymphocytic Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Micrographic surgery for the microscopically controlled excision of eyelid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Management of periocular basal cell carcinoma: Mohs' micrographic surgery versus radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Microscopically Controlled Excision of Malignant Neoplasms on and around Eyelids Followed by Immediate Surgical Reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Mohs surgery: Techniques, indications, and applications in head and neck surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

Chemosurgical reports: perineural spread of basal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.03033.X

10.1046/J.1365-2133.1999.03033.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference